Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug
Renaud CapdevilleNovartis Pharma AG, S-27 2.033, CH-4002 Basel, Switzerland. [email protected]Elisabeth BuchdungerNovartis Oncology, Novartis Pharma AG, S-27 2.033, Basel, CH-4002, SwitzerlandJuerg ZimmermannNovartis Oncology, Novartis Pharma AG, S-27 2.033, Basel, CH-4002, SwitzerlandAlex MatterNovartis Oncology, Novartis Pharma AG, S-27 2.033, Basel, CH-4002, Switzerland
2002en
ABI
Abstract
No abstract available.
Identifiers
Citations and references
Cited by 20 references